News, Transactions, and Industry Insights

News and analysis from PharmaBioSource: announcements of closed transactions, commentary on pharma and biotech deal activity, and operator-level views on the trends shaping life sciences M&A, real estate, diligence, and licensing. All content is written by senior advisors with operating experience in the asset classes we cover.

News

October 29, 2026

Why Reshoring Generic Drugs Is So Hard

Reshoring generic drug manufacturing to the United States sounds like an obvious fix for chronic drug shortages, and yet it rarely happens. We sat down with Lori Hoffman of PharmaBioSource, a veteran of generic and injectable drug manufacturing, to talk through the real barriers to supply chain resilience: the economics, the buyers, the quality tradeoffs, […]

Read More